Prescribing sleep, provoking harm? rethinking Z-drugs in heart failure

Charles Fauvel^{1

2}, Iana Simova^{3

4

5

6}

Affiliations

¹ Cardiology Department, FHU CARNAVAL, Rouen University Hospital, Rouen, France.
² INSERM EnVI U1096, Rouen University Hospital, Rouen, France.
³ Cardiology Clinic, MHAT Heart and Brain, 2 Pier Currie Str, Pleven 5800, Bulgaria.
⁴ Bulgarian Cardiac Institute, Bulgaria.
⁵ Medical University, Pleven, Bulgaria.
⁶ Chair of Circulatory Expert Panel, European Medicines Agency.

Editorial

Charles Fauvel et al. Eur J Prev Cardiol. 2025.

. 2025 Jun 12:zwaf277.

doi: 10.1093/eurjpc/zwaf277. Online ahead of print.

Charles Fauvel^{1

2}, Iana Simova^{3

4

5

6}

¹ Cardiology Department, FHU CARNAVAL, Rouen University Hospital, Rouen, France.
² INSERM EnVI U1096, Rouen University Hospital, Rouen, France.
³ Cardiology Clinic, MHAT Heart and Brain, 2 Pier Currie Str, Pleven 5800, Bulgaria.
⁴ Bulgarian Cardiac Institute, Bulgaria.
⁵ Medical University, Pleven, Bulgaria.
⁶ Chair of Circulatory Expert Panel, European Medicines Agency.

No abstract available

Conflict of interest statement

Conflict of interest: none declared.

Z-drugs are associated with cardiovascular outcomes among patients with heart failure: a population-based cohort study in Hong Kong.
Yang HY, Ren QW, Cai AP, Huang JY, Guo R, Gu WL, Zhang JN, Li XL, Yang RQ, Yiu KH. Yang HY, et al. Eur J Prev Cardiol. 2025 Mar 26:zwaf128. doi: 10.1093/eurjpc/zwaf128. Online ahead of print. Eur J Prev Cardiol. 2025. PMID: 40138674